TARS — Tarsus Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Tarsus Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	172	217	227	291	417
Net Total Accounts Receivable
Net Total Receivables	0.092	3.58	17.7	48.1	87.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	176	225	256	357	523
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.83	1.53	3.35	2.87	21.7
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	179	228	265	377	562
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	11.5	15.4	36.9	80.6	136
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	12.2	35	68.5	152	219
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	167	193	197	225	343
Total Liabilities & Shareholders' Equity	179	228	265	377	562
Total Common Shares Outstanding